Logo image of SENS

SENSEONICS HOLDINGS INC (SENS) Stock Fundamental Analysis

NYSEARCA:SENS - NYSE Arca - US81727U1051 - Common Stock - Currency: USD

0.5018  -0.02 (-3.5%)

After market: 0.5011 0 (-0.14%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SENS. SENS was compared to 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of SENS have multiple concerns. SENS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SENS has reported negative net income.
In the past year SENS has reported a negative cash flow from operations.
In the past 5 years SENS reported 4 times negative net income.
In the past 5 years SENS always reported negative operating cash flow.
SENS Yearly Net Income VS EBIT VS OCF VS FCFSENS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -84.85%, SENS is doing worse than 78.19% of the companies in the same industry.
SENS has a Return On Equity of -210.24%. This is in the lower half of the industry: SENS underperforms 76.06% of its industry peers.
Industry RankSector Rank
ROA -84.85%
ROE -210.24%
ROIC N/A
ROA(3y)-13.99%
ROA(5y)-136.34%
ROE(3y)-16.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SENS Yearly ROA, ROE, ROICSENS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K

1.3 Margins

The Gross Margin of SENS (7.19%) is worse than 81.91% of its industry peers.
SENS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SENS Yearly Profit, Operating, Gross MarginsSENS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K

More info and screens

3

2. Health

2.1 Basic Checks

SENS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SENS has been increased compared to 1 year ago.
SENS has more shares outstanding than it did 5 years ago.
SENS has a worse debt/assets ratio than last year.
SENS Yearly Shares OutstandingSENS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
SENS Yearly Total Debt VS Total AssetsSENS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -12.14, we must say that SENS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -12.14, SENS is not doing good in the industry: 83.51% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.99 indicates that SENS is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.99, SENS is not doing good in the industry: 77.66% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF N/A
Altman-Z -12.14
ROIC/WACCN/A
WACC8.87%
SENS Yearly LT Debt VS Equity VS FCFSENS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

2.3 Liquidity

A Current Ratio of 6.88 indicates that SENS has no problem at all paying its short term obligations.
SENS has a Current ratio of 6.88. This is amongst the best in the industry. SENS outperforms 86.17% of its industry peers.
SENS has a Quick Ratio of 6.49. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
SENS's Quick ratio of 6.49 is amongst the best of the industry. SENS outperforms 86.70% of its industry peers.
Industry RankSector Rank
Current Ratio 6.88
Quick Ratio 6.49
SENS Yearly Current Assets VS Current LiabilitesSENS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.43% over the past year.
Looking at the last year, SENS shows a small growth in Revenue. The Revenue has grown by 1.64% in the last year.
SENS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.08% yearly.
EPS 1Y (TTM)21.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y18.01%
Revenue growth 5Y1.08%
Sales Q2Q%23.97%

3.2 Future

The Earnings Per Share is expected to grow by 17.21% on average over the next years. This is quite good.
SENS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 46.80% yearly.
EPS Next Y19.53%
EPS Next 2Y13.33%
EPS Next 3Y9.7%
EPS Next 5Y17.21%
Revenue Next Year60.03%
Revenue Next 2Y47.83%
Revenue Next 3Y42%
Revenue Next 5Y46.8%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SENS Yearly Revenue VS EstimatesSENS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
SENS Yearly EPS VS EstimatesSENS Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SENS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SENS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SENS Price Earnings VS Forward Price EarningsSENS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SENS Per share dataSENS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.33%
EPS Next 3Y9.7%

More info and screens

0

5. Dividend

5.1 Amount

SENS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SENSEONICS HOLDINGS INC

NYSEARCA:SENS (6/13/2025, 8:04:00 PM)

After market: 0.5011 0 (-0.14%)

0.5018

-0.02 (-3.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners10.87%
Inst Owner Change8.4%
Ins Owners3.5%
Ins Owner Change6.57%
Market Cap398.34M
Analysts76
Price Target2.04 (306.54%)
Short Float %6.79%
Short Ratio9.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.42%
Min EPS beat(2)14.75%
Max EPS beat(2)34.09%
EPS beat(4)3
Avg EPS beat(4)9.8%
Min EPS beat(4)-14%
Max EPS beat(4)34.09%
EPS beat(8)5
Avg EPS beat(8)7.57%
EPS beat(12)7
Avg EPS beat(12)1.66%
EPS beat(16)10
Avg EPS beat(16)-26.92%
Revenue beat(2)2
Avg Revenue beat(2)6.89%
Min Revenue beat(2)3.49%
Max Revenue beat(2)10.29%
Revenue beat(4)3
Avg Revenue beat(4)3.18%
Min Revenue beat(4)-3.55%
Max Revenue beat(4)10.29%
Revenue beat(8)6
Avg Revenue beat(8)3.09%
Revenue beat(12)9
Avg Revenue beat(12)2.74%
Revenue beat(16)11
Avg Revenue beat(16)3.05%
PT rev (1m)39.54%
PT rev (3m)42.86%
EPS NQ rev (1m)1.77%
EPS NQ rev (3m)22.23%
EPS NY rev (1m)0%
EPS NY rev (3m)22.72%
Revenue NQ rev (1m)-0.56%
Revenue NQ rev (3m)-23.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 16.82
P/FCF N/A
P/OCF N/A
P/B 11.32
P/tB 11.58
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.03
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -84.85%
ROE -210.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.19%
FCFM N/A
ROA(3y)-13.99%
ROA(5y)-136.34%
ROE(3y)-16.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 139.47%
Cap/Sales 9.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.88
Quick Ratio 6.49
Altman-Z -12.14
F-Score3
WACC8.87%
ROIC/WACCN/A
Cap/Depr(3y)70.29%
Cap/Depr(5y)48.74%
Cap/Sales(3y)4.48%
Cap/Sales(5y)3.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y19.53%
EPS Next 2Y13.33%
EPS Next 3Y9.7%
EPS Next 5Y17.21%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y18.01%
Revenue growth 5Y1.08%
Sales Q2Q%23.97%
Revenue Next Year60.03%
Revenue Next 2Y47.83%
Revenue Next 3Y42%
Revenue Next 5Y46.8%
EBIT growth 1Y5.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year20.93%
EBIT Next 3Y12.25%
EBIT Next 5YN/A
FCF growth 1Y11.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.72%
OCF growth 3YN/A
OCF growth 5YN/A